Franklin Street Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-2,050
| Closed | -$38K | – | 162 |
|
2019
Q3 | $38K | Hold |
2,050
| – | – | ﹤0.01% | 154 |
|
2019
Q2 | $54K | Hold |
2,050
| – | – | 0.01% | 154 |
|
2019
Q1 | $53K | Hold |
2,050
| – | – | 0.01% | 154 |
|
2018
Q4 | $47K | Hold |
2,050
| – | – | 0.01% | 143 |
|
2018
Q3 | $66K | Sell |
2,050
-50
| -2% | -$1.61K | 0.01% | 156 |
|
2018
Q2 | $59K | Buy |
2,100
+100
| +5% | +$2.81K | 0.01% | 156 |
|
2018
Q1 | $71K | Hold |
2,000
| – | – | 0.01% | 160 |
|
2017
Q4 | $78K | Hold |
2,000
| – | – | 0.01% | 162 |
|
2017
Q3 | $51K | Hold |
2,000
| – | – | 0.01% | 154 |
|
2017
Q2 | $55K | Hold |
2,000
| – | – | 0.01% | 147 |
|
2017
Q1 | $66K | Hold |
2,000
| – | – | 0.01% | 154 |
|
2016
Q4 | $48K | Hold |
2,000
| – | – | 0.01% | 168 |
|
2016
Q3 | $73K | Hold |
2,000
| – | – | 0.01% | 176 |
|
2016
Q2 | $45K | Hold |
2,000
| – | – | 0.01% | 198 |
|
2016
Q1 | $42K | Hold |
2,000
| – | – | 0.01% | 220 |
|
2015
Q4 | $61K | Hold |
2,000
| – | – | 0.01% | 221 |
|
2015
Q3 | $49K | Hold |
2,000
| – | – | 0.01% | 222 |
|
2015
Q2 | $64K | Hold |
2,000
| – | – | 0.01% | 221 |
|
2015
Q1 | $71K | Sell |
2,000
-5,000
| -71% | -$178K | 0.01% | 206 |
|
2014
Q4 | $159K | Sell |
7,000
-10,000
| -59% | -$227K | 0.03% | 196 |
|
2014
Q3 | $330K | Hold |
17,000
| – | – | 0.06% | 185 |
|
2014
Q2 | $618K | Buy |
+17,000
| New | +$618K | 0.12% | 151 |
|
2013
Q4 | – | Sell |
-1,350
| Closed | -$49K | – | 230 |
|
2013
Q3 | $49K | Sell |
1,350
-800
| -37% | -$29K | 0.01% | 228 |
|
2013
Q2 | $71K | Buy |
+2,150
| New | +$71K | 0.02% | 231 |
|